Explore association of genes in PDL1/PD1 pathway to radiotherapy survival benefit based on interaction model strategy

Abstract Purpose To explore the association of genes in “PD-L1 expression and PD-1 check point pathway in cancer” to radiotherapy survival benefit. Methods and materials Gene expression data and clinical information of cancers were downloaded from TCGA. Radiotherapy survival benefit was defined base...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Junjie Shen, Jingfang Liu, Huijun Li, Lu Bai, Zixuan Du, Ruirui Geng, Jianping Cao, Peng Sun, Zaixiang Tang
Formato: article
Lenguaje:EN
Publicado: BMC 2021
Materias:
Acceso en línea:https://doaj.org/article/8bcd850508ec43e883b408d9504bba18
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:8bcd850508ec43e883b408d9504bba18
record_format dspace
spelling oai:doaj.org-article:8bcd850508ec43e883b408d9504bba182021-11-21T12:14:02ZExplore association of genes in PDL1/PD1 pathway to radiotherapy survival benefit based on interaction model strategy10.1186/s13014-021-01951-x1748-717Xhttps://doaj.org/article/8bcd850508ec43e883b408d9504bba182021-11-01T00:00:00Zhttps://doi.org/10.1186/s13014-021-01951-xhttps://doaj.org/toc/1748-717XAbstract Purpose To explore the association of genes in “PD-L1 expression and PD-1 check point pathway in cancer” to radiotherapy survival benefit. Methods and materials Gene expression data and clinical information of cancers were downloaded from TCGA. Radiotherapy survival benefit was defined based on interaction model. Fast backward multivariate Cox regression was performed using stacking multiple interpolation data to identify radio-sensitive (RS) genes. Results Among the 73 genes in PD-L1/PD-1 pathway, we identified 24 RS genes in BRCA data set, 25 RS genes in STAD data set and 20 RS genes in HNSC data set, with some crossover genes. Theoretically, there are two types of RS genes. The expression level of Type I RS genes did not affect patients' overall survival (OS), but when receiving radiotherapy, patients with different expression level of Type I RS genes had varied survival benefit. Oppositely, Type II RS genes affected patients' OS. And when receiving radiotherapy, those with lower OS could benefit a lot. Type II RS genes in BRCA had strong positive correlation and closely biological interactions. When performing cluster analysis using these related Type II RS genes, patients could be divided into RS group and non-RS group in BRCA and METABRIC data sets. Conclusions Our study explored potential radio-sensitive biomarkers of several main cancer types in an important tumor immune checkpoint pathway and revealed a strong association between this pathway and radiotherapy survival benefit. New types of RS genes could be identified based on expanded definition to RS genes.Junjie ShenJingfang LiuHuijun LiLu BaiZixuan DuRuirui GengJianping CaoPeng SunZaixiang TangBMCarticleCancersRadio-sensitivityGene biomarkersPD-1 check point pathwayInteraction modelMedical physics. Medical radiology. Nuclear medicineR895-920Neoplasms. Tumors. Oncology. Including cancer and carcinogensRC254-282ENRadiation Oncology, Vol 16, Iss 1, Pp 1-19 (2021)
institution DOAJ
collection DOAJ
language EN
topic Cancers
Radio-sensitivity
Gene biomarkers
PD-1 check point pathway
Interaction model
Medical physics. Medical radiology. Nuclear medicine
R895-920
Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
spellingShingle Cancers
Radio-sensitivity
Gene biomarkers
PD-1 check point pathway
Interaction model
Medical physics. Medical radiology. Nuclear medicine
R895-920
Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
Junjie Shen
Jingfang Liu
Huijun Li
Lu Bai
Zixuan Du
Ruirui Geng
Jianping Cao
Peng Sun
Zaixiang Tang
Explore association of genes in PDL1/PD1 pathway to radiotherapy survival benefit based on interaction model strategy
description Abstract Purpose To explore the association of genes in “PD-L1 expression and PD-1 check point pathway in cancer” to radiotherapy survival benefit. Methods and materials Gene expression data and clinical information of cancers were downloaded from TCGA. Radiotherapy survival benefit was defined based on interaction model. Fast backward multivariate Cox regression was performed using stacking multiple interpolation data to identify radio-sensitive (RS) genes. Results Among the 73 genes in PD-L1/PD-1 pathway, we identified 24 RS genes in BRCA data set, 25 RS genes in STAD data set and 20 RS genes in HNSC data set, with some crossover genes. Theoretically, there are two types of RS genes. The expression level of Type I RS genes did not affect patients' overall survival (OS), but when receiving radiotherapy, patients with different expression level of Type I RS genes had varied survival benefit. Oppositely, Type II RS genes affected patients' OS. And when receiving radiotherapy, those with lower OS could benefit a lot. Type II RS genes in BRCA had strong positive correlation and closely biological interactions. When performing cluster analysis using these related Type II RS genes, patients could be divided into RS group and non-RS group in BRCA and METABRIC data sets. Conclusions Our study explored potential radio-sensitive biomarkers of several main cancer types in an important tumor immune checkpoint pathway and revealed a strong association between this pathway and radiotherapy survival benefit. New types of RS genes could be identified based on expanded definition to RS genes.
format article
author Junjie Shen
Jingfang Liu
Huijun Li
Lu Bai
Zixuan Du
Ruirui Geng
Jianping Cao
Peng Sun
Zaixiang Tang
author_facet Junjie Shen
Jingfang Liu
Huijun Li
Lu Bai
Zixuan Du
Ruirui Geng
Jianping Cao
Peng Sun
Zaixiang Tang
author_sort Junjie Shen
title Explore association of genes in PDL1/PD1 pathway to radiotherapy survival benefit based on interaction model strategy
title_short Explore association of genes in PDL1/PD1 pathway to radiotherapy survival benefit based on interaction model strategy
title_full Explore association of genes in PDL1/PD1 pathway to radiotherapy survival benefit based on interaction model strategy
title_fullStr Explore association of genes in PDL1/PD1 pathway to radiotherapy survival benefit based on interaction model strategy
title_full_unstemmed Explore association of genes in PDL1/PD1 pathway to radiotherapy survival benefit based on interaction model strategy
title_sort explore association of genes in pdl1/pd1 pathway to radiotherapy survival benefit based on interaction model strategy
publisher BMC
publishDate 2021
url https://doaj.org/article/8bcd850508ec43e883b408d9504bba18
work_keys_str_mv AT junjieshen exploreassociationofgenesinpdl1pd1pathwaytoradiotherapysurvivalbenefitbasedoninteractionmodelstrategy
AT jingfangliu exploreassociationofgenesinpdl1pd1pathwaytoradiotherapysurvivalbenefitbasedoninteractionmodelstrategy
AT huijunli exploreassociationofgenesinpdl1pd1pathwaytoradiotherapysurvivalbenefitbasedoninteractionmodelstrategy
AT lubai exploreassociationofgenesinpdl1pd1pathwaytoradiotherapysurvivalbenefitbasedoninteractionmodelstrategy
AT zixuandu exploreassociationofgenesinpdl1pd1pathwaytoradiotherapysurvivalbenefitbasedoninteractionmodelstrategy
AT ruiruigeng exploreassociationofgenesinpdl1pd1pathwaytoradiotherapysurvivalbenefitbasedoninteractionmodelstrategy
AT jianpingcao exploreassociationofgenesinpdl1pd1pathwaytoradiotherapysurvivalbenefitbasedoninteractionmodelstrategy
AT pengsun exploreassociationofgenesinpdl1pd1pathwaytoradiotherapysurvivalbenefitbasedoninteractionmodelstrategy
AT zaixiangtang exploreassociationofgenesinpdl1pd1pathwaytoradiotherapysurvivalbenefitbasedoninteractionmodelstrategy
_version_ 1718419136053248000